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1. Introduction  
Peptide affinity reagent technology including bacterial display encapsulates an in vitro 
analog of classical Darwinian evolution through a physical linkage between polypeptide 
sequence and the encoding of genetic information. Similar to the inate human imune system 
a unique binder is isolated, however, in this directed evolution method a large library 
displaying billions of diverse peptide sequences is created and the sythetic binder to the 
target of interest is determined. Subsequently the synthetic reagent is mass-produced for use 
in the specific biosensing application (Park & Cochran, 2010; Stratis-Cullum & Sumner 
2008). 
Currently, a number of systems, including messenger ribonucleic acid (mRNA) and 
ribosome display (Wilson, Keefe, & Szostak, 2001 ), eukaryotic virus display (Bupp and 
Roth, 2002; Muller, 2003), and bacterial and yeast surface display (Georgiou et al., 1997, 
Boder & Wittrup, 1997), are used to rapidly generate affinity reagents that can be used for 
diagnostics, proteomics, and therapeutic applications (Kodadek, 2001; Nixon, 2002). 
Bacterial cell surface display is advantageous because the use of bacterial cells simplifies the 
polypeptide selection method and enables fast screening of potential recognition elements 
typically using fluorescence activated cell-sorting (FACS) and/or magnetic activated cell-
sorting (MACS). Polypeptide affinity reagents can offer more stable alternatives to antibody 
technology, enabling more rugged application in the field (e.g., enhanced thermal stability). 
A key advantage of bacterial display technology over traditional antibody creation as well 
as other peptide display alternatives is that it offers an strategy for generating tailor-made 
affinity ligands in a very short time period of several days (Georgiou et al., 1997; Bessette, 
Rice and Daugherty 2004), see Figure 1.  
The development of a bacterial display system suitable for robust reagent discovery has 
proven challenging (Lee, Choi & Xu, 2003). There are three main challenges in creating a 
high speed affinity ligand isolation technology against unknown/un-catalogued pathogens: 
(1) creation of a large (high diversity) and robust cell based library, (2) creation of an 
ultrahigh throughput, disposable screening system, and (3) gaining a fundamental 
understanding of the factors which influence binder performance along with this 
understanding the development of methodologies to enable universal isolation and 
optimization of ligand binder performance.  
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Fig. 1. Comparison of time to develop reagents using various reagent methodologies. 
The first challenge is critical to any synthetic library. In general,  the larger the pool of 
mutants and the longer the polypeptide sequence, the greater the potential pool of binders 
from which the sequences with the desired properties are isolated. However, the 
reproducible control over the expression and ease, speed, and robustness of associated 
isolation protocols are also key to practical implementation across varied laboratory 
settings. The second challenge is also critical to practical and routine reagent isolation, as the 
high throughput processing and removal of human bias and error throughout the selection 
process is critical. Coupled with this, the ability to perform the isolation in a contained area 
or disposable unit is ideal for many biohazard applications, to minimize human exposure.  
Sorting, or screening of peptide libraries for suitable reagent candidates is typically 
performed by a combination of several rounds of manual MACS for pre-enrichment and 
several rounds of FACS. Although effective, the approach is quite labor intensive, and most 
importantly, the performance characteristics of the resulting reagents are highly operator 
dependent. Furthermore, the cost of an instrument equipped with full FACS sorting and 
isolation is often prohibitively expensive (~$350-500K) for many laboratories. Consequently, 
the ability to automate the process on an inexpensive platfrom is highly desired. 
There are several key capabilities that must be considered in the evaluation of any potential 
platform for library cell-sorting. For example, high throughput screening is desired to 
handle large libraries (several mL of > 1010 member libraries) in a reasonable time frame 
(several minutes). Typically with the currently employed sorting technologies relying on a 
combination of MACS and FACS sorting, the throughput is determined by the MACS 
sample pre-enrichment prior to FACS sorting since fluorescence cell sorting methods using 
ultra high-speed sorting only approach 100,000 cells/sec (Leary, 2005). The recovery 
(fraction of binders collected relative to the total number of binders in the naïve library) is 
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also critical to affinity ligand development and  to applications in medicine for cell 
identification, such as cancer cell isolation and population enrichment (Lara et al., 2004; Xu 
et al., 2009; & Krivacic et al., 2004). The purity of the isolated fraction is another 
consideration since the goal is to isolate the rare population of binder clones, without the 
other library clones present in order to enrich the binding pool in subsequent growth cycles. 
We reported recently on our approach to address both the challenges in diversity and 
reproducible isolation through the combination of two innovative technologies, microfluidic 
cell sorting, and bacterial display technology (Stratis-Cullum, Kogot, & Pellegrino, 2008; 
Sooter et al., 2009; Zhang et al., submitted for publication). Previous work by the Daugherty 
lab, details the development and early screening results with the eCPX platform (Rice & 
Daugherty, 2008). Briefly, this peptide library employs an E. coli bacterial display platform, 
generated from the extracellular loop of OmpX outer-membrane protein (see Figure 2). The 
randomizedportion of the library is a 15-mer, yielding a greater than 1010 member library. In 
the library utilized throughout these studies is an enhanced form, termed eCPX. The OmpX 
outer membrane protein has been engineered into a circularly permuted scaffold to allow 
both C-terminal and N-terminal display of proteins.  
 
 
Fig. 2. Schematic diagram of eCPX E. coli display library containing greater than 1010 library 
of 15 randomized residues on the N-terminal. 
To address the need for a rapid, safe, efficient, cost effective, and reproducible method for 
peptide affinity ligand isolation, we previously developed an automated magnetic bacterial 
cell-sorting system, the micromagnetic cell sorter (MMS) shown in Figure 3 (Stratis-Cullum, 
Kogot & Pellegrino, 2010). The system is equipped with a disposable polypropylene 
microfluidic cartridge and is capable of autoclave sterilization. The aim is to contain the 
mixing, incubation, high performance magnetic trapping and isolation of library binders 
within the disposable cartridge to minimize human error, human exposure, and automate 
the sorting process for reproducible sorting. 
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Fig. 3. Photograph of the semi-automated Micro Magnetic Sorter (MMS) platform and 
disposable polypropylene cartridge for fluid handling and peptide ligand isolation. 
To demonstrate the sorting ability of the MMS system to isolate peptide binders, protective 
antigen (PA) protein of Bacillus anthracis was chosen for evaluation. The eCPX (CytomX 
Therapeutics) bacterial display library (Rice, 2008), expressing ~3 x 1010 discreet random 
peptides, was screened for affinity reagents capable of binding to protective antigen. Of 
note, comparable results to manual MACS and FACS screening were obtained (Stratis-
Cullum, Kogot & Pellegrino, 2010). In addition, excellent recovery performance through 
MMS selection yielded a consensus sequence among 24 unique binders and directly 
correlates to a MACS/FACS binder sequence.  
Despite the promise of rapid selection of peptides for detection, initial selections do not 
typically yield the most specific or highest affinity binders and often require continued 
experimental optimization and selection stringency with variable results (Park & Cochran, 
2010). Currently, soft randomization of peptide display libraries provides the most 
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convenient method to achieve the highest binding affinity for isolated peptides. The third 
major challenge in affinity reagent isolation identified above stems from these inherent 
limitations from any directed evolution/biopanning library methodology. The selection of 
affinity ligands is performed typically without prior knowledge of the target. Depending on 
the stringency of selection, and criteria of selection many clones will be excluded from 
propagation early in the process. Moreover, there are fundamental biases in starting library 
composition as well as statistical losses throughout the emperical sorting methods. Often the 
highest affinity binder is selected, while the specificity of the binding element (equally 
critical to successful implementation in a biosensor device) is not optimized. Alternatively, 
specificity can be a criteria of  selection, particularly through controlled negative sorting 
rounds. In either case, there is an affinity maturation process that must be employed to 
optimize back the best binders which may not have propagated during the selection process. 
There are also performance issues with moving in an on-cell format during the selection 
process, to off-cell in a solubilized peptide reagent format that must be considered when 
characterizing potential reagent performance. 
In this paper, we have chosen protective antigen (PA) of an anthrax toxin (Bacillus anthracis) 
as a target and performed peptide reagent isolation studies using the eCPX library and the 
high performance sorting technology we previously developed known as the Micro 
Magnetic Sorter (MMS). In these studies we compare the binding performance of the 
isolated clones on scaffold (cell) to both the PA target and a streptavidin negative control to 
evaluate relative cross-reactivity. Finally, we compare the best on-scaffold peptide candidate 
to the off-scaffold performance. 
2. Materials and methods 
2.1.1 MMS disposable microfluidic card 
The Micro-Magnetic Sorter (MMS) is an automated magnetic separation system consisting 
of a disposable microfluidic cartridge and a companion instrument (Figure 3). The 
disposable cartridges are made of injection-molded polypropylene (Pinnacle Polymers PP 
5135C). The 200 µm deep fluidic channels are defined by two injected parts, which are laser-
welded (California Lasers, Simi Valley, CA) and a portion is heat staked with a hydrophobic 
membrane for bubble removal (Pall Co, Ann Arbor, MI). The trapping region was designed 
to accommodate up to 1 x 109 of 1 µm trapped magnetic beads and process up to 1 x 1011 
bacterial cells. Female luer fittings on the top of the cartridge allow for a leak-proof interface 
between the cartridge and disposable syringes (Becton Dickinson, San José, CA). The luer 
fittings on the cartridge are designed to hold a reservoir array, for pneumatically driven 
applications as well as the injector inputs. There are a total of four luer ports required for 
two sample injectors (1 or 5 mL volume), one running/wash buffer injector (up to 10 mL) 
and one elution buffer injector (up to 3 mL volume). Strategically designed micro-channels 
allow for full automation of magnetic separation on the cartridge. To accomplish this, five 
pneumatically actuated pinch valves are located on the underside of the cartridge, which 
allow for the redirection of flow. These valve membranes require a force of ~15 lb/in2 to seal 
and are robust enough to be actuated multiple times. 
2.1.2 MMS Instrumentation 
The instrument utilizes a cRIO controller with LabVIEW script (National Instruments, 
Austin, TX) outfitted with standard digital and analog in/out modules for control of the 
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internal components. Flow rates within the cartridge are controlled by four stepper motors 
(Figure 7c) and controller boards (Haydon and Anaheim Automation, respectively), which 
physically push on the injectors (Figure 7d). These motors are fitted with micro-switches 
(Panasonic ECG, Secaucus, NJ) that allow for the automatic calculation of input volume. 
Valves on the cartridge are actuated using pneumatically controlled air cylinders (SMC 
Corp, Noblesville, IN) and a DC diaphragm pump (Thomas provided by Nor Cal Controls, 
San Jose, CA). There are seventy custom neodymium-iron boron magnets, which are 
position-controlled by another Haydon stepper motor. The magnets are distributed equally 
among top and bottom portions of a magnetic rack, which sandwich the disposable 
cartridge. A single motor, in conjunction with a spring, allows for both horizontal and 
vertical movement of magnets. This facilitates horizontal movement required for trapping 
and elution, and vertical movement capable of agitating the sample within the cartridge. 
Software control is provided using a LabVIEW interface. Push button applications have 
been created for bacterial library sorting. Advanced users can generate custom sorting 
routines, which allow full access to all the operation parameters with minimal training. 
Direct control of flow rates, wash stringencies, and positive/negative selection criteria 
enables the end user to specify the magnetic bead and protocol of choice, and optimize it for 
applications beyond bacterial library sorting (i.e. cell culture, flow cytometry, toxicology 
studies, etc.). 
2.2 Sorting procedures and sample preparation 
Figure 4 shows a general schematic of the library sorting scheme. A bacterial display library 
(Cytomx Therapeutics; San Francisco, CA: eCPX library) which contains approximately 3 × 
1010 members was screened for clones that display PA binding peptides. The random library 
is first grown in 500 mL LB media containing 25 µg/mL chloramphenicol (LB-Cm25) to  an 
OD600nm of approximately 0.6 (Eppendorf Biophotometer; Eppendorf, Hamburg, Germany). 
At this point in exponential growth phase the cells were induced by the addition of 
arabinose to a final concentration of 0.04% (w/v); the enhanced circularly permuted OmpX 
(eCPX) gene expressing the library peptides is under the control of an arabinose inducible 
promoter (Rice, 2008). The cells were shaken at 37 °C for an additional 45 mins, after which 
the OD600nm was again measured and, using the assumption that an OD600nm of 1.0 relates to 
a bacterial concentration of 1 x 109 cfu/mL, approximately 2 x 1011 cells were pelleted by 
centrifugation at 3000g for 20 mins.  
2.3 Streptavidin-binder depletion 
The bacterial pellet was re-suspended in 1.5mL of PBSB (PBS buffer plus 0.5% BSA) containing 
1 x 109 paramagnetic beads (Invitrogen DynabeadsMyOneStreptavidin C-1; Invitrogen, 
Carlsbad, CA). The cell suspension was incubated at 4 ºC for 45 mins with rotation to allow 
depletion of streptavidin binders from the library prior to selections. To remove these beads 
and any cells bound to them the sample was loaded onto an MMS cartridge and separated at a 
sample flow rate of 50 mL/hr and buffer flow rate of 10 mL/hr. The MMS cartridge captured 
the unwanted bead bound cells and allowed collection of the depleted library ready for 
enrichment. SA binder depletion was performed using using a benchtop magnetic bead 
separator (manual MACS). The bacterial cell pellet with 1 x 109 paramagnetic beads was 
pelleted using a magnet next to the tube. The magnetic separation was performed for 5 mins to 
allow the bead pellet to form, the sample was washed and aspirated with 5 x 1 mL PBS 
washes, and resuspended in 1 mL PBSB for PA binder enrichment.  
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Fig. 4. Schematic diagram of library sorting inputs, and outputs using eCPX technology and 
target conjugation to magnetic bead for trapping within disposable cartridge. 
2.4 PA-binder enrichment 
The SA-binder depleted library was centrifuged at 3000 g for 20 mins, resuspended in 1mL 
PBSB buffer containing 600 nM biotinylated protective antigen (List Biological Laboratories, 
Inc; Campbell, CA), and incubated at 4 ºC for 45 mins. Cells were centrifuged as above and 
re-suspended in 1 mL PBSB buffer with 1 x 109 pre-washed magnetic beads. After 45 mins at 
4 ºC with rotation, the cell-beads suspension was loaded into an MMS cartridge (or 
separated by manual MACS using the same methods as SA binder depletion). Bacterial cells 
bound to PA were trapped on cartridge, and then eluted into a collection vessel. A second 
round of sorting was performed following the same protocol as the first; however, the assay 
parameters were adjusted to account for the smaller starting population and to increase the 
selection pressure in the second round, therefore 1 x 108 cells in 50 µL of 300 nM PA and 1 x 
108 magnetic beads were used. Cells were incubated static on ice for all labeling steps. Also, 
1 µM biotin was added in the washing buffer to compete with any remaining streptavidin 
binders (peptides which bind to streptavidin typically have a much lower affinity than 
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biotin). In the third round of MMS sorting, cells were labeled with 150 nM biotinylated PA, 
and then labeled with 1 x 106 magnetic beads in 50 µL of PBSB. After each round of magnetic 
separation, the bead-bound enriched library was added to LB-Cm25 media supplemented 
with 0.2% glucose to inhibit expression of the eCPX gene and therefore prevent growth bias. 
The cultures were then grown overnight at 37 oC with shaking. 
2.5 Flow cytometry analysis of binder enrichment 
To quantify the library enrichment of potential PA binders, flow cytometry analysis (BD 
FACSAria; BD Biosciences, Franklin Lakes, NJ) was performed using biotinylated PA (EZ-
Link Sulfo-NHS biotinylation kit; Thermo Scientific, Rockford, IL) labeled with alternating 
fluorescent secondary labels: streptavidin, R-phycoerythrin conjugate (SAPE; Invitrogen, 
Carlsbad, CA), anti-biotin-phycoerythrin (Miltenyi Biotec; Bergisch Gladbach, Germany), 
and Neutravidin, R-phycoerythrin conjugate (NAPE; Invitrogen, Carlsbad, CA), similar to 
previously published procedures (Georgiou et al., 1997; Daugherty, Iverson, & Geogiou, 
2000). Following each round of PA selection, the arabinose induced cell population was 
incubated with 100 nM biotin-PA solution for 45 mins. The sample was centrifuged at 3000 g 
for 10 mins to remove unbound biotin-PA and was resuspended in a 25 L solution of PBSB 
with secondary label concentration of 5 g/mL and incubated for 45 mins at 4 ºC. The 
sample was centrifuged and resuspended in 1 mL ice-cold BD FACSFlow (BD Biosciences, 
Franlin Lakes, NJ) sheath immediately prior to flow cytometry. Cells labeled with SAPE 
exhibit increased red fluorescence and are easily distinguishable by flow cytometry. 
2.6 Immunoassay characterization  
ELISA analysis for each of the peptides was completed using a Maxisorp (Nalge Nunc; 
Rochester, NY) 96-well plate by initially dissolving each peptide at 10 g/ml in 0.2 M 
sodium bicarbonate buffer (pH=9.5). The peptides were diluted serially across the row of 
the plate beginning with the 10 mg/ml stock peptide solution (typically 10, 5, 2.5, 1.25, 0.675, 
0.338, 0.169, 0.084, 0.042, and 0.021 g/ml). A single row of buffer was used as a negative 
control. Following a 2-hour incubation for peptide binding to the plate surface, each well 
was blocked for 1 hour using PBS (pH=7.4) + 0.1% Tween (PBST). Protective Antigen (PA) 
was labeled with a horseradish peroxidase enzyme using EZ-Link Plus Activated 
Peroxidase (Thermo Fisher Scientific; Rockford, IL) and was used at 0.2 g/ml in PBST to 
determine the total PA binding to each peptide at varying peptide concentrations. After a 45 
min incubation period of the PA with each peptide, the wells were washed with PBS and 
detected using 1-Step Ultra TMB ELISA substrate (Thermo Fisher Scientific; Rockford, IL) 
according to the manufacturers recommended procedure. The data was recorded as total 
absorbance at 450 nm using a Syntergy HT Microplate reader (Biotek; Winooski, VT). The 
binding dissociation constant (Kd) was determined by plotting the total absorbance versus 
the concentration of peptide and fit using a sigmoid function with IGOR Pro (WaveMetrics 
Inc.; Lake Oswego, OR). 
3. Results and discussion 
Previously, we demonstrated the effectiveness eCPX technology for bacterial library sorting 
and the capability of automating the selection using the MMS platform (Stratis-Cullum, 
Kogot, & Pellegrino, 2008; Sooter et al., 2009; Zhang et al., submitted for publication).   
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Advantages to this approach include reproducible reagent isololation in disposable 
cartridge format to avoid exposure to potentially harmful threat materials which may be the 
target system under investigation. For a typical 1 mL sample volume, MMS requires only 5 
mins of user interaction, while manual selection requires more than 20 mins. With reagent 
sorting,  there are three key parameters that are critical to evaluate with the first being 
throughput, i.e. how many cells can be sorted per second. The MMS platform achieves high 
throughput screening since it is capable of screening a bacterial library containing 3 × 1010 
members in 15 mins. With regard to gross throughput per hour, MMS is able to process 5 × 
1012 cells/hr (50 mL/hr at a cell concentration of 1 x 1011 cells/mL), which is four orders of 
magnitude higher than that achieved using state-of-art FACS instrumentation or a 
previously reported dielectrophoretic cell sorter (Hu et al., 2005). In this work, we utilize the 
MMS sorter platform to rapidly isolate peptide binders from the eCPX platform to the target 
Protective Antigen (PA) from Bacillus anthracis. Three rounds of reagent isolation were 
performed by two separate users and isolated clones from all three sorting populations were 
evaluated using flow cytometry analysis.  
Flow cytometry is a powerful tool for determining the relative binding of  microscopic 
particles, such as cells to a target of interest by separating them in a stream of fluid and 
performing optical analysis of the light scattering and fluorescence observed from an 
incorporated dye label or tag. (Daugherty, Iverson & Georgiou, 2000)   In this work, our 
target PA material is tagged with a  red fluorescent label (SAPE) which is easily 
distinguished by flow cytometry analysis.  
Figure 5 compares the binding results for two isolated clones using fluorescence activated 
cell sorting (flow cytometry) analysis. In all cases the binding population is indicated in red 
and the overall percentage of the population determined as binding to the target or 
interferent is given. It is clear that there is very little binding to the cell or library scaffold 
itself, designated as the negative control panels a) and d) for the DS-28 and SM545 binders, 
respectively. It is clear upon examination of panels 5b and 5e, that both DS-28 and SM545 
exhibit marked binding to the protective antigen target, with the SM545 binder exhibiting 
superior performance (95.4 % binding). Negative sorting is performed during the selection 
process to remove potentially cross-reactivity with the bead chemistry used for reagent 
isolation. However, it is necessary to evaluate the degree of cross-reactivity for any isolated 
reagent to have practical relevance. Figure 5 c and f show the cross-reactivity to streptavidin 
for the clones DS-28 and SM545, respectively. From these data it is clear that both clones 
exhibit cross-reactivity to streptavidin and in the case of DS-28, the binding population to 
streptavidin is even greater than that to the target. The binding to the target PA over the 
streptavidin is significantly greater, however, for the SM545 clone at 95.4% (PA) and 24% 
(Streptavidin).  
A summary of the top 10 binders arranged in order of highest percentage of the population 
binding to PA is provided in Table 1 along with associated streptavidin binding 
percentages. All analysis was performed on-cell (i.e., on-scaffold) using fluorescence 
activated cell sorting. It is not surprising that clones isolated from the eCPX library exhibit 
activity to streptavidin, as streptavidin was used in the coupling chemistry of the PA to the 
magnetic bead. What is surprising is that despite classical negative sorting against the 
streptavidin beads used in the reagent clone isolation, significant activity to streptavidin is 
still evident. Future sorting experiments have been adjusted to remove streptavidin from the 
sorting, and instead employ direct coupling of the magnetic bead and the target protein. 
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Fig. 5. Flow cytometry analysis of two peptide reagent candidates designated DS-28 (a,b, c) 
and SM545, designated d, e, f. The binding to the cell scaffold alone is illustrated in a) for 
DS-28 and d) for SM545. The binding to the PA target is illustrated in b and c and c) and f) 
represents the fraction which binds to streptavidin. In all panels, the binding population is 
indicated in red. 
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Name Sequence PA (%) Strep (%) 
 
 
SM545 GSFYDSILFYCMTCR 95.4 24.0 
 
 
SM589 FYCHYVFCDFYRPFG 93.3 77.1 
 
 
SM574 YLHTTYAQYLTWYSP 82.9 59.4 
 
 
DS28 VNHVRPHASPRWLLY 39.9 50.9 
 
 
SM583 TPRDILSPYFRNWWL 42.4 25.0 
 
 
SM575 IKTLLEMMFFQRNSG 23.7 26.9 
 
 
SM579 YYYHLIEDWYHGNP 15.7 17.1 
 
 
DS25 GSNLRSTRTETHCTN 15.4 13.9 
 
 
DS21 RHNHCGSAHATPYRT 12.2 13.0 
 
 
SM541 IIHFIHHHAKETHSH 11.4 4.4 
 
Table 1. Sample table of the top binders to protective antigen (PA) sorted by the % of the 
population which binds to PA. The % binding to streptavidin is also tabulated. 
In order for a peptide reagent to have practical use ultimately in a variety of potential assay 
formats, it is critical that the peptide performance is characterized off-cell or off-scaffold. 
Despite being such a critical barrier to success, this off-scaffold characterization is typically 
not investigated throughout the peptide library sorting literature. To investigate this further 
in our studies, the randomized portion of the best candidate clone SM545 was synthesized 
(GSFYDSILFYCMTCR).  
 
 
Fig. 6. Schematic diagram illustrating two possible peptide configurations including a 
disulfide bridge (a) and reduced form (b). 
One challenge when dealing with affinity reagent development using bacterial or other 
library display technology is the potential for differences is binding behavior on-scaffold 
and off-scaffold. Furthermore, the actual structure of the displayed peptide on-scaffold is 
not known. For example, the SM545 peptide above could be displayed in at least two 
different presentations shown in Figure 6. Figure 6a illustrates a possible hairpin structure 
formed from between the thiol groups of two cysteine residues creating a disulfide bridge. 
Figure 6b illustrates a simpler, linear peptide where this bond has been reduced. 
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Consequently, the SM545 was synthesized for testing with the disulfide bridge intact and 
also in a reduced format.  
Flow cytometry analysis using FACS gives  a relative estimate of binding performance with 
a general trend that the greater % binding to the target, the greater the affinity should be for 
that target should be. To obtain a more quantitative assessment of binding performance of 
the synthetic peptides, a peptide-based enzyme-linked immunosorbent assay (ELISA) was 
developed utlilizing the peptide as a capture step. There are advantages and disadvantages 
to the incorporation of the peptide reagent as the capture vs. the detector reagent in the 
immunossay. These considerations include steric issues and interferences from label 
modifications amoung others. To avoid the complexity and cost of a synthetic dye label and 
the associated interactions of the label with the target analyte, we chose to integrate the 
peptide into a capture reagent for the purpose of these studies.  
To determine the binding constant, the peptide binding to PA was investigated as a function 
of peptide concentration. In these experiments the PA was HRP labeled and an absorbance 
endpoint was measured. The binding dissociation constants (Kd) were obtained by fitting 
the data using a sigmoid function and were determined to be 770.19 nm ± 26.4 for the SM545 
sequence containing the disulfide bridge (Figure 7a) and 616.93 nm ± 7.48 for the reduced 
form (Figure 7b). The binding constants are virtually identical (considering experimental 
error) and consequently the hairpin structure does not appear to play a critical role in the 
binding interaction. However, the binding constants for both forms are impressive for 
synthetic peptide performance off-scaffold without optimization of binder sequence using 
affinity maturation techniques.    
These results not only demonstrate the potential of bacterial display technology and  
automated reagent discovery but could lead to a much broader extension to a variety of 
applications requiring rare-cell recovery. For example, the ability to consistently recover and 
isolate a rare cell population from a large negative control population provides a useful 
method for pathogen detection in food and water using this low cost, disposable cartridge 
system. The use of a disposable cartridge permits the analysis of potentially hazardous 
materials with minimal user exposure and eliminates any concerns for cross-contamination 
of samples. Above all, the MMS performs with consistency and can be coupled with display 
libraries to rapidly isolate peptide affinity binders for sensing, diagnosis, or detection of 
potential biohazard threats, such as protective antigen of Bacillus anthracis.  
4. Conclusion 
In this chapter, we describe the challenges of bacterial display isolation of peptide ligands 
for biosensing applications, report on semi-automated isolation of binders to Protective 
Antigen from Bacillus anthracis using the MMS approach, and investigate binding 
performance of isolated clones to include affinity and specificity studies. Several clones 
exhibited significant affinity to the target species, with many exhibiting significant cross-
reactivity to streptavidin despite negative sorting used conventionally in peptide selection. 
This emphasizes the importance of utilizes both affinity and specificity studies to evaluate 
best candidate reagents prior to affinity maturation. We characterized the best candidate 
peptide from these studies off-scaffold through an ELISA-type assay and found impressive 
binding affinity for the free-solubized format which is also a critical consideration for 
practical assay integration of synthetic reagent alternatives. The ease and speed at which 
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Fig. 7. Binding affinity study using ELISA of SM545 peptide (a) with disulfide bridge and (b) 
reduced form.  
new reagents can be developed makes the bacterial display technology an attractive 
alternative to antibody technology. Future directions include development of a modeling 
toolkit to address the optimization of binder performance in terms of both affinity and 
specificity to be performed in-silico. This will further reduce the time-to-reagent.  
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